IMARC Group, a leading market research company, has recently released a report titled “Connected Drug Delivery Devices Market Size, Share, Trends, and Forecast by Product, End User, Technology, and Region, 2025-2033”. The study provides a detailed analysis of the industry, including the connected drug delivery devices market size, share, growth, trends and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global connected drug delivery devices market size was valued at USD 1,081.78 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 8,142.87 Million by 2033, exhibiting a CAGR of 23.13% from 2025-2033.
Request to Get the Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample
Factors Affecting the Growth of the Connected Drug Delivery Devices Industry:
Rise of Telehealth and Remote Patient Monitoring
The market for Connected Drug Delivery Devices is expanding, thanks to telehealth and remote monitoring. Digital health technologies are making care easier and more efficient. These devices let doctors track patients’ medication use and effects from a distance. This cuts down on the need for in-person visits, crucial for chronic conditions. Continuous monitoring leads to better health outcomes. The COVID-19 pandemic increased telehealth use, making patients more comfortable with digital tools. Now, there’s a growing demand for devices that enable remote monitoring and communication with doctors. This trend is boosting innovation and investment in the sector.
Enhanced Data Analytics and Artificial Intelligence Integration
Connected drug delivery devices now use advanced data analytics and AI. This shift is changing the market. These technologies gather and analyze large patient data sets. They enable personalized treatments and better medication management. By 2025, these devices will predict patient behavior and optimize doses using AI. They will offer tailored health recommendations. This boosts patient involvement and aids doctors in making informed decisions. As healthcare adopts data-driven methods, the demand for these smart devices will increase. They will become vital in modern healthcare.
Growing Focus on Compliance and Adherence Solutions
Following medication plans is tough, especially for chronic diseases. Connected drug delivery devices are solving this. They offer reminders, track use, and provide feedback. By 2025, more devices aimed at improving patient compliance will hit the market. These devices allow doctors to monitor patients and step in if needed. The growing understanding of medication importance and the rise in chronic diseases will boost demand. Thus, devices that focus on compliance will significantly improve health and lower costs.
Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=3738&flag=C
Connected Drug Delivery Devices Market Report Segmentation:
Analysis by Product:
- Connected Sensors
- Connected Inhaler Sensors
- Connectable Injection Sensors
- Integrated Connected Devices
- Connected Inhalation Devices
- Connected Injection Devices
Integrated connected devices, comprising connected inhalation and injection devices, dominate the market with a 56.8% share in 2024, driven by their ability to combine medication delivery with advanced monitoring features, enhancing patient care through real-time data on usage, adherence, and treatment outcomes.
Analysis by End User:
- Hospitals and Healthcare Providers
- Homecare
Hospitals and healthcare providers, accounting for 59.3% of the market share in 2024, lead the market due to their critical need for efficient patient care, improved medication adherence, and better treatment outcomes facilitated by connected devices that streamline medication management, enable remote monitoring, and support data-driven decision-making.
Analysis by Technology:
- Bluetooth
- NFC
- Other Technologies
Bluetooth, accounting for 61.8% of the market share in 2024, leads the market due to its low power consumption, seamless data transmission, wide compatibility, reliability, security, and cost-effectiveness, enabling efficient operation, real-time monitoring, and easy integration into healthcare systems.
Regional Analysis:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America dominates the market in 2024 with a 41.2% share, driven by rising healthcare expenditure, strong R&D investments by pharmaceutical and medical device companies, and supportive regulatory frameworks.
Global Connected Drug Delivery Devices Market Trends in 2025:
The Connected Drug Delivery Devices Market is set for major change, thanks to technology and patient needs. Healthcare is moving towards more integrated and patient-focused methods. This highlights the growing role of connected devices in managing medications. By 2025, these devices are expected to do more than just deliver drugs. They will also monitor health. Features like sharing data with doctors, sending reminders, and offering tailored advice will improve patient involvement and adherence. Moreover, partnerships between drug and tech companies will spark innovation. This will lead to advanced devices that meet diverse patient needs. As more people see the benefits of these systems in improving health and making care easier, the market will keep growing. This growth will shape the future of drug delivery and patient management.
Top Companies Operated in Connected Drug Delivery Devices Industry:
- Adherium Ltd.
- BioCorp Production
- Cohero Health Inc. (AptarGroup Inc.)
- Elcam Medical ACS. Ltd
- Findair Sp. z o. o.
- Merck KGaA
- Phillips Medisize (Molex LLC)
- Propeller Health (Resmed Inc.)
- Teva Pharmaceutical Industries Ltd.
- West Pharmaceutical Services Inc.
Key Highlights of the Report:
- Market Performance (2019–2024)
- Market Outlook (2025–2033)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: +1–631–791–1145
